Related Experiment Videos
Therapy with parent's lymphocyte transfer factor in children with infection and malnutrition
Insights
Transfer factor (T.F.) administration reduced diarrheal disease episodes in young Aboriginal children. This immune modulation therapy showed no protection against other common childhood infections.
Area of Science:
- Immunology
- Pediatrics
- Public Health
Background:
- Acute infections and protein-calorie malnutrition are significant health issues in young Australian Aboriginal children.
- The immune system's role in recovery from infection and malnutrition is critical for child development.
Purpose of the Study:
- To evaluate the efficacy of transfer factor (T.F.) in preventing recurrent infections in Australian Aboriginal children.
- To assess the impact of T.F. on diarrheal disease and other common infections in a vulnerable pediatric population.
Main Methods:
- A randomized, blind study involving 40 Australian Aboriginal children (2-46 months) treated with T.F. and 35 controls.
- Children received T.F. prepared from parent's lymphoid cells.
- Outcomes, including infection episodes, were monitored for at least 12 months.
Main Results:
- T.F.-treated children experienced significantly fewer episodes of diarrheal disease lasting over 26 weeks.
- Recurrent moderate diarrhea was notably reduced.
- A potential delay in the onset of severe gastroenteritis was observed.
- No protective effect was found against chest, middle-ear, or skin infections.
Conclusions:
- Transfer factor (T.F.) shows promise in reducing the burden of diarrheal diseases in young Australian Aboriginal children, particularly those with malnutrition.
- T.F. therapy may be a valuable intervention for specific infectious diseases in pediatric populations.
- Further research is needed to explore T.F.'s broader applications and limitations in pediatric infectious disease management.
Abstract:
Transfer factor (T.F.) prepared from 5 x 10(8) lymphoid cells from 500 ml of a parent's blood was given to 40 Australian aboriginal children aged 2-46 months who had been in hospital with acute infection. Many had protein-calorie malnutrition. These and a control group of 35 similar children were assessed blind for at least 12 months. In T.F.-treated children there were significantly fewer episodes of diarrhoeal disease for periods in excess of 26 weeks. Recurrent moderate diarrhoeal disease was particularly reduced, and the onset of severe gastroenteritis may have been delayed. There was no protection against chest, middle-ear, or skin infection.